Key facts

Active Substance
Dirucotide acetate
Therapeutic area
Neurology
Decision number
P/43/2009
PIP number
EMEA-000433-PIP01-08
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Multiple Sclerosis
Route(s) of administration
Intravenous use
Contact for public enquiries

Eli Lilly & Company Limited

E-mail: eu_paediatric@lilly.com 
Tel. +44 (0)1276 483000

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
Decision date

Decision

P/43/2009: European Medicines Agency decision of 23 March 2009 on the refusal of a product specific waiver for dirucotide acetate (EMEA-000433-PIP01-08) in accordance with Regulation (EC) No 1901/2006 of the European Par...

How useful do you find this page?